Currently, some in the medical community dont buy the idea that a supplement can give you similar results as GLP-1 receptor agonists
they may adjust dose or frequency or recheck vitamin levels as needed
The rationale for this approach was to investigate if GLP-1 signalling could cause metabolic reprograming that would persist after removal of receptor stimulation (Fig
NuMedica has added a full complement of vitamins and minerals, supplying at least 30% of the recommended daily value per serving, including the highest quality, active forms of B vitamins methylcobalamin and pyridoxal 5-phosphate.* We have also added premium ingredients such as MatriCal and BrocColinate
For weekly medications, the timing has less impact on side effects due to their steady-state pharmacokinetics
These companies will need to understand how their demand may be impacted in the future, which part of their markets will be most affected, how their portfolio could evolve to mitigate the impact and how they can establish themselves as complementary to GLP-1RAs